Cited by 140Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase SignalingSignaling Pathways in Disease

Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases

Lambrecht, Caroline, Haesen, Dorien, Sents, Ward, Ivanova, Elitsa, Janssens, Veerle·2013·Methods in Molecular Biology

Abstract

Protein phosphatases of the type 2A family (PP2A) represent a major fraction of cellular Ser/Thr phosphatase activity in any given human tissue. In this review, we describe how the holoenzymic nature of PP2A and the existence of several distinct PP2A composing subunits allow for the generation of multiple structurally and functionally different PP2A complexes, explaining why PP2A is involved in the regulation of so many diverse cell biological and physiological processes. Moreover, in human disease, most notably in several cancers and Alzheimer's Disease, PP2A expression and/or activity have been found significantly decreased, underscoring its important functions as a major tumor suppressor and tau phosphatase. Hence, several recent preclinical studies have demonstrated that pharmacological restoration of PP2A activity, as well as pharmacological PP2A inhibition, under certain conditions, may be of significant future therapeutic value.

Integrity signals

Registry

Crossref · 10.1007/978-1-62703-562-0_17

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CIP2A is the most prevalent oncoprotein among PP2A inhibitor proteins.

    “Among them, cancerous inhibitor of PP2A (CIP2A) is the most prevalent oncoprotein”
  • The therapeutic effects of inhibition of CIP2A protein expression have been validated by numerous studies.

    “This is a very important finding because the therapeutic effects of inhibition of CIP2A protein expression have been validated by numerous studies [6 -8,10 -12,21].”
  • PP2A is a family of Ser/Thr phosphatases made of a catalytic C subunit and a structural A subunit, usually bound to a regulatory B-type subunit.

    “Protein Phosphatase 2A (PP2A) encompasses a large family of Ser/Thr phosphatases, consisting of a catalytic C subunit and a structural A subunit that are, in most cases, further bound to a regulatory B-type subunit.”
  • In mammals, the C and A subunits are each encoded by two genes, producing α and β isoforms.

    “In mammals, both subunits are each encoded by two distinct genes, leading to an α and β protein isoform.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lambrecht, C., Haesen, D., Sents, W., Ivanova, E., & Janssens, V.
Affiliations
KU Leuven (BE)
Venue
Methods in Molecular Biology
Publisher
Humana Press
Published
2013
Volume
1053
Pages
283-305
ISSN
  • 1064-3745 (ISSN-L)
  • 1940-6029
OpenAlex
W151043947
Cited by
140
References
171
Citations by year
2026: 6 · 2025: 9 · 2024: 4 · 2023: 16 · 2022: 16 · 2021: 13 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 14 · 2016: 21 · 2015: 3 · 2014: 12 · 2013: 2
FWCI
16.61
Type
book chapter
Language
en
Open access
closed
Locations
  • Methods in molecular biology (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
protein phosphatase 2A, PP2A regulatory subunit, serine/threonine phosphatase, tumor suppressor, Alzheimer's disease, cancer, PP2A inhibitors
MeSH terms
Alzheimer Disease, Enzyme Inhibitors, Humans, Isoenzymes, Neoplasms, Holoenzymes, Enzyme Activators, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review